HAPPY FRIDAY TO THE STREET

Oof. Nvidia (NVDA) sank 14% today, locking in a seventh straight weekly loss. That’s its longest skid since the Great Recession, with the chip giant erasing $2.5T in market cap along the way.

The worst part? It’s not just Nvidia, and it’s not just retail investors panic selling. Corporate America has swapped buybacks for share sales on any stock linked to the AI trade. Net new share issuance now equals 3.1% of total market cap, according to Acadian Asset Management (AAMI).

For anyone hoping to buy the dip, the so-called smart money appears happy to print more supply.

  • 🟥 | US stocks plummeted today, dropping the DJIA and S&P 500 into correction territory and erasing the Nasdaq Composite’s YTD gain.

  • 📈 | One Notable Gainer: Walmart (WMT) rose as investors fled to defensive stocks.

  • 📉 | One Notable Decliner: Anthropic (ANT) tumbled nearly 10% in its first full day of trading after yesterday’s IPO pop.

— Brooks & The Street Sheet Team

MARKET SNAPSHOT

S&P 500 Heatmap. Credit: Unusual Whales

Market Movers

APPLE, HUMANA, MICRON

📉 | Apple (AAPL) slid following a report that it is developing its own AI agent.

📈 | Humana (HUM) climbed on an upgrade to Buy.

📉 | Micron Technology (MU) sank as AI build-out stocks sold off.

📈 | Gap (GAP) topped Q3 earnings estimates.

📉 | Intuit (INTU) cut its fiscal 2027 revenue outlook, citing a Credit Karma slowdown.

Tomorrow's Trade Idea, Today

SECOND OPINION

Stock Spotlight

  • Stock: UnitedHealth Group (UNH)

  • Firm: TD Cowen (TD)

  • Current Price: $340

  • Price Target: $455

  • Implied Upside: 34%

Looking for more upside? Street Sheet Research members get 1 stock pick from the Top 10% of analysts with 100%+ implied upside each month. Subscribe today.

Upgraded Coverage

UnitedHealth has spent three months in the waiting room. TD Cowen thinks the doctor is finally ready to see it.

Analyst Ryan Langston upgraded the health insurer to Buy, arguing it has a credible path to mid-to-high-teens EPS growth through at least 2028.

Optum-istic Outlook

Langston’s case leans on three legs: Medicare Advantage benefit design, a recovery at patient care unit Optum Health, and improvement in the commercial and Medicare-Medicaid dual plans.

He expects Optum Health to post another year of solid margin expansion in 2027. Outside growth at Optum Rx and the rollout of Optum Insight’s AI-first products are also on his watch list.

Strength in Numbers

The stock has slumped as policy headwinds pile up. A proposed federal anti-fraud rule has stoked fears of tougher scrutiny on its Medicare Advantage business.

Langston doesn’t see that derailing the Optum story. And he’s not alone: of the 28 analysts covering the stock, 25 rate it a Buy or Strong Buy.

That’s a lot of second opinions pointing the same way.

Do you own shares of UnitedHealth Group (UNH)?

(Drop us a note and tell us why.)

Login or Subscribe to participate

OVERHEARD ON THE STREET

🔎 The SEC opened a probe into Nvidia, reportedly to examine potential accounting issues.

🖥️ President Trump threatened a “tremendous tax” on US companies that build data centers abroad.

✈️ Hopper estimates Thanksgiving and Christmas airfares are up 39% and 40% from last year.

🏛️ Fed governor Lisa Cook said skipping an October rate hike risks leaving the Fed behind on inflation.

🧮 An Anthropic mathematician says Claude helped him prove the Riemann hypothesis, math’s most famous unsolved problem.

THURSDAY’S POLL RESULTS

Do you own shares of Box (BOX)?

▇▇▇▇▇▇ 🐂 Yup, I’m holding

▇▇▇▇▇▇ 🐻 Nope, not interested

▇▇▇▇▇▇ 👀 No, but I’m interested

And, in response, you said:

  • 🐻 Nope, not interested — “This stock has already rallied hard and the growth in earnings really isn't all that impressive. Looks like another overvalued AI stock. No thanks.”

Reply

Avatar

or to participate